Study of YK012 in B-cell Acute Lymphoblastic Leukemia

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

B-cell Acute Lymphoblastic Leukemia

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Sun Yat-sen Memorial Hospital, Guangzhou, Guangdong, China

    Contact: Study coordinator (Danian Nie)
  • Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China

    Contact: Study coordinator (Yang Liang, MD)
  • Guangdong Provincial People's Hospital, Guangzhou, Guangdong, China

    Contact: Study coordinator (Peilong Lai, MD)
  • The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China

    Contact: Study coordinator (Jishi Wang, MD)
  • Henan Provincial People's Hospital, Zhengzhou, Henan, China

    Contact: Study coordinator (Zunmin Zhu, MD)
  • The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China

    Contact: Study coordinator (Zhenyu Li, MD)
  • The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China

    Contact: Study coordinator (Fei Li, MD)
  • The First Hospital of Jilin University, Changchun, Jilin, China

    Contact: Study coordinator (Sujun Gao, MD)
  • Affiliated Zhongshan Hospital of Dalian University, Dalian, Liaoning, China

    Contact: Study coordinator (Meiyun Fang, MD)
    Contact: Study coordinator (Xiang Li)
  • Shengjing Hospital of China Medical University, Shenyang, Liaoning, China

    Contact: Study coordinator (Wei Yang, MD)
  • The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China

    Contact: Study coordinator (Zeping Zhou, MD)
  • The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China

    Contact: Study coordinator (Jie Jin, MD) · jiej0503@163.com · +86-0571-87236898
Study leads
  • Jie Jin, MD

    Principal Investigator

    Zhejiang University